Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/4737
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | van Belle, S. | - |
dc.contributor.author | Cocquyt, V. | - |
dc.contributor.author | Bleiberg, H. | - |
dc.contributor.author | Canon, J.L. | - |
dc.contributor.author | BUYSE, Marc | - |
dc.contributor.author | Hulstaert, F. | - |
dc.contributor.author | Dewitte, M. | - |
dc.contributor.author | de Keyser, P. | - |
dc.contributor.author | Westelinck, K.J. | - |
dc.date.accessioned | 2007-12-20T15:52:11Z | - |
dc.date.available | 2007-12-20T15:52:11Z | - |
dc.date.issued | 1995 | - |
dc.identifier.citation | Anti-cancer drugs: supplement, 6. p. 22-30 | - |
dc.identifier.uri | http://hdl.handle.net/1942/4737 | - |
dc.title | Optimal combination therapy with navoban (tropisetron) in patients with incomplete control of chemotherapy induced nausea and vomiting | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 30 | - |
dc.identifier.spage | 22 | - |
dc.identifier.volume | 6 | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | - | |
item.accessRights | Closed Access | - |
item.contributor | van Belle, S. | - |
item.contributor | Cocquyt, V. | - |
item.contributor | Bleiberg, H. | - |
item.contributor | Canon, J.L. | - |
item.contributor | BUYSE, Marc | - |
item.contributor | Hulstaert, F. | - |
item.contributor | Dewitte, M. | - |
item.contributor | de Keyser, P. | - |
item.contributor | Westelinck, K.J. | - |
item.fullcitation | van Belle, S.; Cocquyt, V.; Bleiberg, H.; Canon, J.L.; BUYSE, Marc; Hulstaert, F.; Dewitte, M.; de Keyser, P. & Westelinck, K.J. (1995) Optimal combination therapy with navoban (tropisetron) in patients with incomplete control of chemotherapy induced nausea and vomiting. In: Anti-cancer drugs: supplement, 6. p. 22-30. | - |
item.fulltext | No Fulltext | - |
Appears in Collections: | Research publications |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.